Results 231 to 240 of about 1,138,451 (355)

Toward Natural Limb Function: A New Era in Prosthetic Innovation

open access: yesAnnals of Neurology, EarlyView.
The past decade has witnessed groundbreaking clinical implementation of neuroprosthetic limbs driven by signals from peripheral targets (eg, nerves and muscle) and the brain to restore limb function for individuals with limb loss or impairment. In this review, we highlight recent key clinical trials in peripheral neuroprosthetic interfaces directly ...
Yucheng Tian   +4 more
wiley   +1 more source

Distribution of Cavitations as Identified with Accelerometry During Lumbar Spinal Manipulation [PDF]

open access: green, 2011
Gregory D. Cramer   +8 more
openalex   +1 more source

Microneedle interventional therapy combined with cervical spine manipulation for cervicogenic dizziness [PDF]

open access: yes, 2018
Duan, Junfeng   +10 more
core   +1 more source

Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis

open access: yesAnnals of Neurology, EarlyView.
Objective Despite its clinical heterogeneity, amyotrophic lateral sclerosis is unified by early and prominent alterations in cortical excitability, increasingly recognized as contributors to disease progression. This study assessed whether the ratio between motor evoked potential (MEP) amplitude, reflecting upper motor neuron integrity, and compound ...
Federico Ranieri   +41 more
wiley   +1 more source

Spinal manipulation and mobilisation for paediatric conditions: time to stop the madness. [PDF]

open access: yesJ Man Manip Ther
Olson KA   +7 more
europepmc   +1 more source

Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy

open access: yesAnnals of Neurology, EarlyView.
Objective Exenatide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, has neuroprotective effects in preclinical models of multiple system atrophy (MSA). We investigated these effects in a proof‐of‐concept clinical trial. Methods In this single‐center, randomized, open label trial, participants with MSA were randomly assigned (1:1) to receive ...
Nirosen Vijiaratnam   +29 more
wiley   +1 more source

Home - About - Disclaimer - Privacy